⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRBP News
Corbus Pharmaceuticals Holdings, Inc.
In Vitro Toxicology Testing Market worth $20.97 billion by 2031 | MarketsandMarkets™
prnewswire.com
TMO
LH
BIO
CRBP
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea
globenewswire.com
CRBP
Form 8-K
sec.gov
CRBP
Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers
globenewswire.com
CRBP
Form 8-K
sec.gov
CRBP
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
globenewswire.com
CRBP
KRYS
Form 8-K
sec.gov
CRBP
IPSC
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
globenewswire.com
IPSC
CRBP
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
CRBP
Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody USA - English APAC - Traditional Chinese APAC - English
prnewswire.com
CRBP